Medtronic Plc (NYSE:MDT) shares traded 3.52% higher at $82.68 on Wall Street last session.
MDT stock price is now -2.48% away from the 50-day moving average and -1.77% away from the 200-day moving average. The market capitalization of the company currently stands at $106.02B.
With the price target enhanced from $98 to $105, RBC Capital Mkts Upgraded its rating from Sector Perform to Outperform for Medtronic Plc (NYSE: MDT). On August 21, 2024, Oppenheimer reiterated its ‘Perform’ rating on the stock by increasing its target price from $92 to quote $94, while ‘UBS’ rates the stock as ‘Neutral’
In other news, Wall Brett A., Officer bought 9,850 shares of the company’s stock on Jan 08 ’25. The stock was bought for $792,038 at an average price of $80.41. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 31 ’24, Former Director PARKHILL KAREN L bought 30,000 shares of the business’s stock. A total of $2,691,794 was incurred on buying the stock at an average price of $89.73. A total of 0.08% of the company’s stock is owned by insiders.
During the past 12 months, Medtronic Plc has had a low of $75.96 and a high of $92.68. As of last week, the company has a debt-to-equity ratio of 0.58, a current ratio of 1.84, and a quick ratio of 1.39. According to the stock market information, the enterprise value for the company is $132568342528, which is based on a 25.23 price-to-earnings ratio, a 4.39 price-to-earnings-growth ratio, and a beta of 0.84. The fifty day moving average price for MDT is $84.7826 and a two-hundred day moving average price translates $84.168 for the stock.
The latest earnings results from Medtronic Plc (NYSE: MDT) was released for 2024-07-26. The net profit margin was 13.00% and return on equity was 8.58% for MDT. The company reported revenue of $7.92 billion for the quarter, compared to $7.7 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 2.77 percent.
